Human Immunodeficiency Virus-associated Heart Disease in Nigerian Children: A Persistent and Difficult Clinical

Ijeoma Ogugua Arodiwe1

  • 1Department of Paediatrics, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria.

Insights

Childhood heart disease is a significant complication of human immunodeficiency virus (HIV) infection, affecting 38.2%–75.9% globally. Management is challenging in developing countries due to limited resources and comorbidities.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Heart disease is a common end-organ damage in patients with human immunodeficiency virus (HIV)/AIDS.
  • The global incidence of HIV-associated heart disease ranges from 20% to 40%.

Purpose of the Study:

  • To review the prevalence and management challenges of childhood HIV-associated heart disease in a developing country.
  • To highlight the need for routine cardiovascular screening in children with HIV.

Main Methods:

  • A literature search was conducted using keywords such as 'HIV', 'heart disease', 'HAART', 'end organ involvement in HIV', 'echocardiography', and 'children'.
  • Data on prevalence and management challenges were extracted from published studies.

Main Results:

  • Global prevalence of HIV-associated heart disease is high (38.2%–75.9%), including left ventricular (LV) diastolic and systolic dysfunction, dilated cardiomyopathy, pericardial effusion, and LV hypertrophy.
  • Specific echocardiographic findings like elevated mitral valve peak E/A ratio and prolonged deceleration time were noted in affected children.
  • Management challenges include a lack of echocardiographic expertise and difficulties in using diuretics due to comorbidities like anemia and diarrheal disease.

Conclusions:

  • HIV-associated heart disease is a prevalent condition in children, presenting significant management challenges in developing nations.
  • Routine screening for cardiovascular abnormalities at baseline and during follow-up is crucial for early detection and management.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
884
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
255
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
141